Details of the Drug Reposition

General Information of This Drug (ID: DMPADR1)

Drug Name
CD19/CD22 Chimeric Antigen Receptor T Cells   DMPADR1
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Mediastinal large B-cell lymphoma DISAUA10 2A60.32 Phase 1 [1]
Acute lymphoblastic leukaemia DIS87TGM 2A85 Phase 1 [1]
B-cell lymphoma DISIH1YQ 2A86 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03233854) CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Patients With Recurrent or Refractory CD19 Positive Diffuse Large B-Cell Lymphoma or B Acute Lymphoblastic Leukemia